The Magazine for Sleep Professionals
Tuesday, February 17, 2026
An estimated one in three adults worldwide experience symptoms of insomnia, yet only a fraction of those suffering have access to specialists trained in cognitive behavioral therapy for insomnia (CBTI)—the gold standard in treatment.1,2 This unmet need has created a major bottleneck in behavioral sleep medicine, where demand far exceeds […]
Sleep medicine is undergoing a profound transformation. What was once centered around episodic, in-lab evaluations is evolving into a more continuous, personalized model of care. With the rapid rise of home sleep testing (HST) and increasingly sophisticated wearables, the integration of remote patient monitoring (RPM) into sleep medicine has moved […]
Specific types of gut bacteria may increase or decrease the risk for insomnia, while insomnia itself may in turn alter the abundance of certain gut bacteria, a new study showed. However, outside experts challenged the investigators’ assertion that the link is causal. Investigators identified 14 groups of bacteria associated with increased […]
From the Dalai Lama’s claim that it is the “best meditation” to Benjamin Franklin’s insistence that it makes a person “healthy, wealthy, and wise,” a good night’s sleep has long been touted as the secret to a healthy life. And the American Heart Association (AHA) agrees. In 2022, the AHA added sleep […]
Topline: Patients with type 2 diabetes (T2D) who experienced sleep impairments, including short sleep duration, snoring, and insomnia symptoms, were more likely to face an increased risk for diabetes distress. In particular, daytime coping difficulties due to sleep problems showed a notably prominent association with diabetes distress. Methodology: Researchers in Norway conducted a cross-sectional […]
Sleep and wakefulness are carefully balanced by a network of brain regions. Yet for many years, scientists couldn’t pinpoint exactly which neurons regulated sleep state transitions. New research tools and a deeper understanding of brain signaling have led to new discoveries in dopamine and norepinephrine signaling, offering novel insights into […]
Alkermes plc today announced positive topline results from the randomized double-blind treatment period of the Vibrance-1 phase 2 study evaluating alixorexton in patients with narcolepsy type 1 (NT1). Alixorexton, formerly referred to as ALKS 2680, is the company’s novel, investigational, oral orexin 2 receptor (OX2R) agonist in phase 2 development as […]
The Sleep To Live Well Foundation issues an urgent warning in its groundbreaking 2025 State of Sleep Wellness Report, titled “THE SILENT EPIDEMIC: How Lack of Sleep Endangers Over Half of All Americans and Threatens Everyone.” The report unveils the Foundation’s initiatives to address this insufficient sleep crisis with Sleep Wellness—a holistic approach to […]
Compumedics Limited is excited to announce the launch of the Falcon, a Home Sleep Testing device now available for sale in the United States. The Falcon is designed to be simple to set up and deploy, enhancing both patient experience and workflow efficiency in home sleep testing. The Falcon HST […]
Empatica, a pioneer in digital biomarker development and patient monitoring using wearables and AI, today unveiled EmbraceMini, its revolutionary new wearable for clinical trials. EmbraceMini is an ultra-compact health monitoring device, focused on delivering exceptional wearability and high-quality data without compromising sponsor or participant needs. With its incredibly small footprint and […]
